Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
nicotinamide (1 trial)
pyridoxine (1 trial)
vitamin c (1 trial)
Schizophrenia (Phase 4)
Trials (1 total)
Trial APIs (3 total)